WallStSmart
KIDS

Orthopediatrics Corp

NASDAQ: KIDS · HEALTHCARE · MEDICAL DEVICES

$15.06
+2.87% today

Updated 2026-04-30

Market cap
$406.36M
P/E ratio
P/S ratio
1.72x
EPS (TTM)
$-1.69
Dividend yield
52W range
$15 – $24
Volume
0.2M

Orthopediatrics Corp (KIDS) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+21.4%
Last 4 quarters
Revenue YoY growth
+17.0%
Most recent quarter
EPS YoY growth
+10.3%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+3.5%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+8.0%
2026-02-27
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-02-27$-0.26+10.3%$17.79$19.22+8.0%
2025-11-05$-0.24+2.9%$16.58$16.40-1.1%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.29$-0.26+10.3%$61.60M+17.0%
2025-09-30$-0.25$-0.24+2.9%$61.25M+12.2%
2025-06-30$-0.29$-0.11+62.1%$61.08M+15.7%
2025-03-31$-0.44$-0.39+10.3%$52.41M+17.3%
2024-12-31$-0.26$-0.29-13.0%$52.67M+40.0%
2024-09-30$-0.24$-0.34-41.7%$54.57M+36.5%
2024-06-30$-0.27$-0.26+3.7%$52.80M+33.5%
2024-03-31$-0.40$-0.34+15.0%$44.69M+41.5%
2023-12-31$-0.28$-0.29-3.6%$37.61M
2023-09-30$-0.23$-0.20+13.0%$39.97M
2023-06-30$-0.22$-0.13+40.9%$39.56M
2023-03-31$-0.36$-0.30+16.7%$31.59M

Frequently asked questions

Has Orthopediatrics Corp beaten earnings estimates?
Orthopediatrics Corp has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +21.4% over the last 4 quarters.
How does KIDS stock react to earnings?
KIDS stock has moved an average of +3.5% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Orthopediatrics Corp's revenue growth rate?
Orthopediatrics Corp reported year-over-year revenue growth of +17.0% in its most recent quarter, with EPS growing +10.3% year-over-year.